Scarica l'app Stockscreener
23.13
0.73%
-0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Roivant Sciences Insider Sold Shares Worth $4,384,000, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences(ROIV.US) Officer Sells US$4.38 Million in Common Stock - 富途牛牛
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares - MarketBeat
Is Roivant Sciences Ltd forming a bullish divergenceJuly 2025 Technicals & Long-Term Growth Stock Strategies - baoquankhu1.vn
Roivant Sciences stock hits all-time high of $23.47 By Investing.com - Investing.com Nigeria
US Market Wrap: Does Roivant Sciences Ltd stock trade at a discount to peers2025 Technical Overview & Stepwise Entry and Exit Trade Signals - Bộ Nội Vụ
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighWhat's Next? - MarketBeat
Discipline and Rules-Based Execution in ROIV Response - Stock Traders Daily
Why Roivant Sciences Ltd. stock could be next big winnerJuly 2025 Sentiment & Low Risk High Reward Ideas - Bộ Nội Vụ
Roivant Sciences stock hits all-time high of $23.47 - Investing.com India
Profit Recap: How risky is Roivant Sciences Ltd stock nowJuly 2025 Highlights & Real-Time Sentiment Analysis - Bộ Nội Vụ
Proxima Raises $80 Million for AI Drug Discovery From DCVA, Nvidia - Bloomberg.com
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 22.84% Potential Upside in Biotech Innovations - DirectorsTalk Interviews
Buyback Watch: Whats the fair value of Roivant Sciences Ltd stockTrade Ideas & Risk Controlled Daily Plans - baoquankhu1.vn
Published on: 2026-01-10 23:30:08 - Улправда
How Roivant Sciences Ltd. (87S) stock reacts to fiscal policiesJuly 2025 Sentiment & Verified Entry Point Signals - Улправда
What margin trends mean for Roivant Sciences Ltd. stock2025 Historical Comparison & Fast Entry Momentum Trade Alerts - Улправда
Aug Ideas: Can NETGEAR Inc stock maintain operating marginsVolume Spike & Weekly Top Performers Watchlists - moha.gov.vn
Can Roivant Sciences Ltd. stock double in next 5 yearsMarket Performance Summary & Weekly Stock Breakout Alerts - Улправда
How Roivant Sciences Ltd. stock reacts to global recession fears2025 Big Picture & Community Supported Trade Ideas - Улправда
Is Roivant Sciences Ltd. stock positioned for digital transformation2025 Investor Takeaways & Target Return Focused Stock Picks - Улправда
How Roivant Sciences Ltd. stock performs in rate cut cyclesWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Aug Big Picture: How Roivant Sciences Ltd. stock reacts to global recession fearsWeekly Earnings Recap & Real-Time Volume Surge Alerts - ulpravda.ru
What Roivant Sciences (ROIV)'s Accelerated Brepocitinib Push Means For Shareholders - simplywall.st
A Look At Roivant Sciences (ROIV) Valuation After Brepocitinib Timeline Acceleration And Profitability Outlook Shift - simplywall.st
Leerink Partners reiterates Outperform rating on Roivant Sciences stock By Investing.com - Investing.com South Africa
Leerink raises price target as Roivant (ROIV) accelerates drug development pipeline - MSN
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus - BioWorld MedTech
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Penn Davis Mcfarland Inc. Buys 170,456 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Pacer Advisors Inc. Makes New Investment in Roivant Sciences Ltd. $ROIV - MarketBeat
Behavioral Patterns of ROIV and Institutional Flows - Stock Traders Daily
Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline - Insider Monkey
Roivant Sciences Insider Sold Shares Worth $28,902,500, According to a Recent SEC Filing - MarketScreener
Book value per share of Roivant Sciences Ltd. – DUS:87S - TradingView — Track All Markets
Mayukh Sukhatme Sells 1,018,995 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Mayukh Sukhatme Sells 311,873 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Short Interest in Roivant Sciences Ltd. (NASDAQ:ROIV) Drops By 16.2% - MarketBeat
15 Best Stocks Under $25 to Buy Now - Insider Monkey
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CEO Sells 75,000 Shares of Stock - MarketBeat
Richard Pulik Sells 406,731 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Roivant Sciences Executives Engage in Significant Share Sales - TradingView — Track All Markets
Eric Venker Sells 200,000 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Capricorn Fund Managers Ltd Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Insider Confidence In December 2025's Leading Growth Companies - Yahoo! Finance Canada
Reassessing Roivant Sciences (ROIV) Valuation After Pipeline Progress, NDA Timelines and Genevant Litigation Updates - simplywall.st
Voya Investment Management LLC Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Is Roivant Sciences Ltd stock positioned for digital transformationGap Down & High Conviction Trade Alerts - moha.gov.vn
Ramaswamy-Backed Ambros Launches with $125M - Orange County Business Journal
Roivant Sciences president Sukhatme sells $619k in shares By Investing.com - Investing.com Australia
Roivant Sciences president Sukhatme sells $619k in shares - Investing.com UK
4.73%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):